www.dynamicpapers.

com

Cambridge Assessment International Education

Cambridge International Advanced Subsidiary and Advanced Level
* 7 7 7 7 7 0 0 6 3 0 *

BIOLOGY 9700/41
Paper 4 A Level Structured Questions May/June 2019
2 hours
Candidates answer on the Question Paper.
No Additional Materials are required.

READ THESE INSTRUCTIONS FIRST

Write your centre number, candidate number and name on all the work you hand in.
Write in dark blue or black pen.
You may use an HB pencil for any diagrams or graphs.
Do not use staples, paper clips, glue or correction fluid.
DO NOT WRITE IN ANY BARCODES.

Section A
Answer all questions.

Section B
Answer one question.

Electronic calculators may be used.

You may lose marks if you do not show your working or if you do not use appropriate units.

At the end of the examination, fasten all your work securely together.
The number of marks is given in brackets [ ] at the end of each question or part question.

This document consists of 24 printed pages.

DC (LK/TP) 164858/2
© UCLES 2019 [Turn over
 www.dynamicpapers.com
2

Section A

Answer all questions.

1 (a) Fig. 1.1 shows part of a cell in a growing region of a plant.

H+ K+ H2O cell
auxin wall

cell
A B C D surface
membrane

stimulation H+ K+ H2 O
cytoplasm

not to scale

Fig. 1.1

(i) State the type of protein represented by A.

...................................................................................................................................... [1]

(ii) Proteins B, C and D are transport proteins.

Identify proteins B, C and D.

B ........................................................................................................................................

C ........................................................................................................................................

D ........................................................................................................................................
[3]

(b) Describe the effects on the cell wall of many hydrogen ions moving into the cell wall.

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

.............................................................................................................................................. [3]

© UCLES 2019 9700/41/M/J/19

 www.dynamicpapers.com
3

(c) Explain the consequences of an influx of potassium ions into the cell.

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

............................................................................................................................................. [2]

[Total: 9]

© UCLES 2019 9700/41/M/J/19 [Turn over

 www.dynamicpapers.com
4

2 The interpupillary distance (IPD) is the distance in millimetres between the centres of the pupils of
the eyes. Fig. 2.1 shows how IPD is measured.

Interpupillary
distance

Fig. 2.1

IPD is one example of a characteristic of human facial structure that shows variation.

Fig. 2.2 shows the pattern of variation in IPD in a large sample of adults.

450
400
350
300
number 250
of people 200
150
100
50
0
50 55 60 65 70 75 80
interpupillary distance (IPD) / mm

Fig. 2.2

(a) (i) Name the type of variation shown in Fig. 2.2.

..................................................................................................................................... [1]

(ii) Suggest and explain how genes and the environment contribute to variation in IPD in
humans.

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

..................................................................................................................................... [3]

© UCLES 2019 9700/41/M/J/19

 www.dynamicpapers.com
5

(b) Individuals with an IPD of 70 mm or more have a mutation in the PAX3 gene that results in
less PAX3 protein being made.

The normal role of the PAX3 protein is to increase the expression of many other genes
involved in embryonic development. These genes affect a range of phenotypic features such
as facial structure, hearing and eye colour.

(i) State the term that is used to describe a gene, such as PAX3, that controls the expression
of other genes and suggest how the PAX3 protein controls the expression of other
genes.

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

..................................................................................................................................... [3]

(ii) Describe how microarray analysis could be used to identify the genes switched on by
PAX3 in embryonic cells.

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

..................................................................................................................................... [5]

© UCLES 2019 9700/41/M/J/19 [Turn over

 www.dynamicpapers.com
6

(iii) The chimpanzee, Pan troglodytes, has DNA that is 98.5% similar to humans, including
possession of the PAX3 gene. Investigations show that chimpanzees express higher
levels of the PAX3 protein during embryonic development than humans.

Fig. 2.3 shows a chimpanzee, Pan troglodytes.

Fig. 2.3

Suggest how knowledge of the PAX3 gene helps scientists explain how humans and
chimpanzees are very different in facial structure, even though they have very similar
DNA.

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

..................................................................................................................................... [3]

[Total: 15]

© UCLES 2019 9700/41/M/J/19

 www.dynamicpapers.com
7

3 Some neurones in the brain produce a neurotransmitter known as dopamine. Parkinson’s disease
occurs when the neurones that produce dopamine die. A person with the disease may experience
difficulty in coordinating movement, often seen as tremors (shaking) in different parts of the body.

Parkinson’s disease typically occurs in people older than 55 years. Younger people with these
symptoms are said to have early onset Parkinson’s disease (EOPD).

Recessive mutations in a gene known as PINK1, located on chromosome 1, an autosome, are

believed to be one cause of EOPD. A person with this form of EOPD has a homozygous recessive
genotype.

(a) Draw a genetic diagram of a cross between two individuals who are heterozygous at the
PINK1 gene locus.

key to symbols used for alleles

....................................

....................................

parental genotypes

gametes

offspring genotypes

ratio of offspring phenotypes

[4]

© UCLES 2019 9700/41/M/J/19 [Turn over

 www.dynamicpapers.com
8

(b) PINK1 codes for a protein kinase enzyme that is important in the functioning of mitochondria
in neurones.

Most recessive PINK1 mutations are base substitutions which lead to the production of a
non-functioning protein kinase enzyme.

Explain how a base substitution mutation can lead to the production of a non-functioning
protein kinase.

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

............................................................................................................................................. [5]

(c) One rare, dominant mutation of the PINK1 gene codes for a product that inhibits the normal
protein kinase.

Explain how this mutation causes EOPD in a heterozygote.

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

............................................................................................................................................. [2]

[Total: 11]

© UCLES 2019 9700/41/M/J/19

 www.dynamicpapers.com
9

Question 4 starts on page 10

© UCLES 2019 9700/41/M/J/19 [Turn over

 www.dynamicpapers.com
10

4 (a) The link reaction and Krebs cycle take place in the mitochondrion.

The main stages of the link reaction and Krebs cycle are listed in Table 4.1.

They are not listed in the correct order.

Table 4.1

stage description of stage

A acetyl group combines with coenzyme A to form acetyl CoA

B citrate is formed

C hydrogen atoms are accepted by NAD and FAD

D oxaloacetate is regenerated

E pyruvate enters the mitochondrial matrix

F acetyl group is formed

G acetyl CoA enters Krebs cycle

H ATP is made by substrate-linked phosphorylation

I pyruvate is decarboxylated and dehydrogenated

J acetyl CoA combines with oxaloacetate

K citrate is decarboxylated and dehydrogenated

© UCLES 2019 9700/41/M/J/19

 www.dynamicpapers.com
11

Complete Table 4.2 to show the correct order of the stages.

Three of the stages have been done for you.

Table 4.2

correct order letter of stage

1 E

2 .........

3 .........

4 .........

5 .........

6 J

7 .........

8 .........

9 .........

10 .........

11 D
[4]

(b) Outline the role of NAD in respiration in aerobic conditions.

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

............................................................................................................................................. [4]

© UCLES 2019 9700/41/M/J/19 [Turn over

 www.dynamicpapers.com
12

(c) Carbon dioxide is removed from compounds in the link reaction and Krebs cycle by
decarboxylation.

(i) State the total number of molecules of carbon dioxide removed in the link reaction and
Krebs cycle for each molecule of glucose respired.

.......................................................... [1]

(ii) In a mammal, carbon dioxide diffuses from cells into the blood to be transported to the
lungs.

Suggest why carbon dioxide is transported in the blood mainly as hydrogen carbonate
ions and not as carbonic acid.

..................................................................................................................................... [1]

[Total: 10]

© UCLES 2019 9700/41/M/J/19

 www.dynamicpapers.com
13

5 Researchers investigated the extent to which the founder effect and natural selection affected
evolutionary change.

Fig. 5.1 shows the brown anole lizard, Anolis sagrei. These lizards live on a number of Caribbean
islands and feed on a variety of invertebrates and other small animals.

perch diameter

Fig. 5.1

A. sagrei spends a lot of time perching (resting) on, or moving along, branches of shrubs and
trees. The width of the branch that A. sagrei perches on is known as the perch diameter, as
labelled in Fig. 5.1.

There is a positive correlation between perch diameter and hind limb length of A. sagrei.
• Longer hind limbs allow A. sagrei to run faster on vegetation with a larger diameter.
• Shorter hind limbs are needed to provide stability on vegetation of a smaller diameter.

In 2004, a hurricane caused the death of all the A. sagrei lizards on seven islands.

In 2005, the researchers randomly collected seven male and seven female lizards from a source
population on a nearby island. For each of the seven islands affected by the hurricane, a male
and female lizard were mated and placed on each island. These islands formed the experimental
founder islands where new populations of A. sagrei were successfully established from each
founding pair.

Fig. 5.2 shows the difference in vegetation between the source island and the seven experimental
founder islands.

source population experimental

founder islands

Fig. 5.2

© UCLES 2019 9700/41/M/J/19 [Turn over

 www.dynamicpapers.com
14

(a) (i) Predict the effect of natural selection on mean hind limb length of A. sagrei on the seven
experimental founder islands.

...........................................................................................................................................

..................................................................................................................................... [1]

(ii) Predict how collecting individuals at random for the seven founding pairs affects the
mean hind limb length of A. sagrei on the different islands.

...........................................................................................................................................

..................................................................................................................................... [1]

(b) Many generations of A. sagrei were produced over the four years after the introduction of the
founding pairs.

Fig. 5.3 shows how the mean hind limb length of A. sagrei changed on the seven experimental
islands and on the source island.

Key: source island

island 1
island 2
island 3
island 4
island 5
island 6
island 7

mean hind
limb length

0 2006 2007 2008 2009

year

Fig. 5.3

© UCLES 2019 9700/41/M/J/19

 www.dynamicpapers.com
15

With reference to Fig. 5.2 and Fig. 5.3, describe and suggest explanations for the results for
the islands.

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

............................................................................................................................................. [5]

(c) In the investigation, one population of A. sagrei was established on each experimental
founder island.

Outline how speciation may occur on the seven experimental founder islands.

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

............................................................................................................................................. [3]

© UCLES 2019 9700/41/M/J/19 [Turn over

 www.dynamicpapers.com
16

(d) Speciation is one possible outcome for the experimental founder populations, but there is
also a high risk that they may become extinct.

Explain why the experimental founder populations are at high risk of extinction.

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

............................................................................................................................................. [3]

[Total: 13]

6 Maize, Zea mays, is an important food crop for human consumption and for feeding to animals.

Two varieties of maize are MON810 and Justina. Justina has been developed in the traditional way
by selective breeding (artificial selection) and MON810 is an example of a genetically modified
(GM) organism.

(a) MON810 produces a chemical that is toxic to insect pests. It is described as insect-resistant.

Outline how genetic engineering gave MON810 the trait of insect resistance.

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

............................................................................................................................................. [4]

© UCLES 2019 9700/41/M/J/19

 www.dynamicpapers.com
17

(b) Countries vary in the extent to which they grow GM varieties such as MON810, instead of
traditional varieties such as Justina.

• In the USA, 88% of the total maize that is grown is GM.

• In most European countries, 0% of the maize that is grown is GM.

Scientists used computer models to predict the effect of two different changes in agricultural
practice on maize crop yields:

• a global ban that reduces the cultivation of GM maize to 0% everywhere

• all countries increasing the cultivation of GM maize to the 88% level of the USA.

Table 6.1 shows the results of this modelling for four countries.

Table 6.1

percentage change in yield of maize

country decrease GM maize increase GM maize
cultivation to 0% of total cultivation to 88% of total
Argentina –8.86 +2.90
Honduras –1.26 +16.75
Spain –3.82 +5.39
USA –7.63 0.00

Explain what the data in Table 6.1 suggests about the social and ethical implications of
growing GM maize.

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

............................................................................................................................................. [4]

[Total:8]

© UCLES 2019 9700/41/M/J/19 [Turn over

 www.dynamicpapers.com
18

7 (a) Some people have a condition called diabetes. In type 1 diabetes the pancreas does not
produce enough insulin.

Fig. 7.1 shows the blood glucose concentrations of a type 1 diabetic person and a non-diabetic
person, at regular intervals after drinking a glucose drink.

250

blood 200
diabetic person
glucose
concentration 150
/ mg 100 cm–3 non-diabetic
100
person

0
0 1 2 3
time / h
glucose
drink taken

Fig. 7.1

(i) Describe the results shown in Fig. 7.1.

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

...........................................................................................................................................

..................................................................................................................................... [3]

(ii) Name the location of the receptors in a non-diabetic person that detect a change in
blood glucose concentration.

..................................................................................................................................... [1]

(iii) Name the homeostatic mechanism by which blood glucose concentration is maintained.

..................................................................................................................................... [1]

© UCLES 2019 9700/41/M/J/19

 www.dynamicpapers.com
19

(b) The urine of a non-diabetic person does not contain glucose. A person with type 1 diabetes
will excrete glucose in urine.

A reading of the concentration of glucose in the urine can be estimated using a dipstick.

Fig. 7.2 outlines how a dipstick works.

enzyme A
glucose gluconic + hydrogen
in acid peroxide
urine

enzyme B
hydrogen + colourless water + coloured
peroxide chromogen chromogen
Fig. 7.2

The higher the concentration of glucose in the urine, the darker the colour on the dipstick.

(i) Name enzymes A and B.

A ........................................................................................................................................

B ........................................................................................................................................
[2]

(ii) An electronic biosensor can be used to measure the glucose concentration in a drop of
blood.

Suggest one advantage of using a biosensor and one advantage of using a dipstick to
measure glucose concentration.

biosensor ...........................................................................................................................

...........................................................................................................................................

dipstick ..............................................................................................................................

...........................................................................................................................................
[2]

© UCLES 2019 9700/41/M/J/19 [Turn over

 www.dynamicpapers.com
20

(c) Describe the role played by insulin in the control of blood glucose concentration.

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

............................................................................................................................................. [5]

[Total: 14]

© UCLES 2019 9700/41/M/J/19

 www.dynamicpapers.com
21

8 Table 8.1 shows the total number of plant species, the total number of insect species and the
number of habitats in three areas, A, B and C.

Table 8.1

total number of plant total number of insect

area number of habitats
species species

A 6 5 1

B 15 23 4

C 362 70 12

(a) Identify the area with the highest biodiversity.

Give reasons for your choice of area.

area ..................

reasons .....................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

...................................................................................................................................................

............................................................................................................................................. [3]

(b) Identify the area that is likely to be affected the most if the environment changes.

Give a reason for your choice of area.

area ..................

reason .......................................................................................................................................

...................................................................................................................................................
[1]

(c) State one reason why it is important to conserve biodiversity in all three areas.

...................................................................................................................................................

...................................................................................................................................................

............................................................................................................................................. [1]

[Total: 5]

© UCLES 2019 9700/41/M/J/19 [Turn over

 www.dynamicpapers.com
22

Section B

Answer one question.

9 (a) Explain what is meant by the term limiting factor and explain how knowledge of limiting factors
is used to increase crop yields in glasshouses. [7]

(b) Describe the behaviour of chromosomes during meiosis. [8]

[Total: 15]

10 (a) Explain how a cholinergic synapse functions. [7]

(b) Describe how you would carry out an investigation into the effect of wavelength of light on the
rate of photosynthesis of a plant, using a redox indicator such as DCPIP. [8]

[Total: 15]

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................
© UCLES 2019 9700/41/M/J/19
 www.dynamicpapers.com
23

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................
© UCLES 2019 9700/41/M/J/19 [Turn over
 www.dynamicpapers.com
24

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

..................................................................................................................................................................

Permission to reproduce items where third-party owned material protected by copyright is included has been sought and cleared where possible. Every
reasonable effort has been made by the publisher (UCLES) to trace copyright holders, but if any items requiring clearance have unwittingly been included, the
publisher will be pleased to make amends at the earliest possible opportunity.

To avoid the issue of disclosure of answer-related information to candidates, all copyright acknowledgements are reproduced online in the Cambridge
Assessment International Education Copyright Acknowledgements Booklet. This is produced for each series of examinations and is freely available to download
at www.cambridgeinternational.org after the live examination series.

Cambridge Assessment International Education is part of the Cambridge Assessment Group. Cambridge Assessment is the brand name of the University of
Cambridge Local Examinations Syndicate (UCLES), which itself is a department of the University of Cambridge.

© UCLES 2019 9700/41/M/J/19